Hypomagnesemia and survival in patients with cervical cancer treated with definitive chemoradiotherapy

Ruth Fullerton,Kevin Martell,Rutvij A. Khanolkar,Tien Phan, Robyn Banerjee, Tyler Meyer, Laurel Traptow,Martin Kobel,Prafull Ghatage,Corinne M. Doll

RADIOTHERAPY AND ONCOLOGY（2023）

引用 0|浏览0

暂无评分

摘要

On-treatment hypomagnesemia ≥ grade 2 (CTCAE v5.0) was associated with worse CSS but did not predict longer treatment duration. This is the first study that shows a detrimental survival impact of on-treatment hypomagnesemia in this patient population. These findings highlight the need to ensure adequate monitoring, support and correction of magnesium during definitive CRT.

查看译文

关键词

hypomagnesemia,cervical cancer,definitive chemoradiotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要